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Abstract
Background: Persistent pathogens have been proposed as risk factors for stroke; however, the evidence remains
inconclusive. Mexican Americans have an increased risk of stroke especially at younger ages, as well as a higher prevalence
of infections caused by several persistent pathogens.
Methodology/Principal: Findings Using data from the Sacramento Area Latino Study on Aging (n = 1621), the authors used
discrete-time regression to examine associations between stroke risk and (1) immunoglobulin G antibody levels to
Helicobacter pylori (H. pylori), Cytomegalovirus, Varicella Zoster Virus, Toxoplasma gondii and Herpes simplex virus 1, and (2)
concurrent exposure to several pathogens (pathogen burden), defined as: (a) summed sero-positivity, (b) number of
pathogens eliciting high antibody levels, and (c) average antibody level. Models were adjusted for socio-demographics and
stroke risk factors. Antibody levels to H. pylori predicted incident stroke in fully adjusted models (Odds Ratio: 1.58; 95%
Confidence Interval: 1.09, 2.28). No significant associations were found between stroke risk and antibody levels to the other
four pathogens. No associations were found for pathogen burden and incident stroke in fully adjusted models.
Conclusions/Significance: Our results suggest that exposure to H. pylori may be a stroke risk factor in Mexican Americans
and may contribute to ethnic differences in stroke risk given the increased prevalence of exposure to H. pylori in this
population. Future studies are needed to confirm this association.
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Introduction
In the United States, stroke is a significant public health issue,
affecting roughly 795,000 individuals annually [1]. Mexican
Americans (MAs) are among the fastest growing populations in
the United States [2], and stroke incidence is higher in MAs than
in Non-Hispanic whites (NHWs), especially at younger ages [3].
Aside from diabetes [4], large ethnic differences in the prevalence
of stroke risk factors do not exist, which suggests that traditional
stroke risk factors are unlikely to fully account for the ethnic
disparity in stroke risk. MAs have a higher prevalence of infections
caused by several persistent pathogens that have been linked to
chronic diseases, including Cytomegalovirus (CMV) [5], Helico-
bacter pylori (H. pylori) [6], Toxoplasma gondii (T. gondii) [7], and
Herpes simplex virus 2 (HSV2) [8]. If persistent pathogen
exposure is a risk factor for stroke, this exposure may contribute
to the ethnic disparity in stroke risk.
Many persistent pathogens are never completely cleared from
the host, and as a result, are prone to reactivation which could lead
to the promotion and/or worsening of atherosclerosis [9,10],
which is the major underlying pathophysiology of ischemic stroke.
[11] Aside from exposure to individual pathogens, total pathogen
burden, or exposure to multiple pathogens concurrently, may
impact stroke risk by invoking a stronger immune system response
than what would be apparent with exposure to a single persistent
infection. Persistent pathogens, traditional risk factors, and genetic
predisposition may work together in stimulating inflammatory
pathways that promote atherosclerosis, which in turn may increase
stroke risk [12].
To date, prospective studies have not identified links between
individual persistent pathogens and incident stroke. Investigators
using data from the Framingham Heart Study (n= 1,187) reported
no association between sero-positivity to Chlamydia pneumoniae
(C. pneumoniae), H. pylori and CMV infections and incident stroke
[13]. Elkind et al. also reported no significant association between
sero-positivity to five infectious pathogens (C. pneumoniae, H.
pylori, CMV, HSV-1 and HSV-2) and stroke risk, in a multi-ethnic
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prospective cohort (n = 1625) with an 8 year (median) follow-up
[14]. Most recently, in a five year prospective cohort study, no
significant association was found between sero-positivity to
cytotoxin associated A-gene negative or positive strains of H.
pylori and stroke risk [15].
The effect of pathogen burden on stroke risk has not been well
studied. Elkind et. al reported a positive association between an
infectious disease burden index, that included several pathogens,
and risk of stroke after multivariable adjustment (Hazard Ratio
(HR):1.39; 95% CI: 1.02, 1.90) [14] which supports the hypothesis
that pathogen burden may be a more important stroke risk factor
than is exposure to individual pathogens. However, other studies,
including Framingham, have not found an association between
pathogen burden and stroke [13,16].
Importantly, the existing studies investigating the link between
persistent pathogens and stroke risk were not focused on the MA
population [3,5,6,7,8]. Further, these studies were limited by their
use of sero-positivity, which is a dichotomous indicator of
pathogen exposure, instead of antibody level to infection, which
may be a more consistent predictor of inflammatory outcomes
[17]. Given these limitations, our objective was to examine the
associations between incident stroke and: (1) antibody levels to five
individual persistent pathogens including previously studied
pathogens (CMV, HSV1, and H. pylori), as well as two novel
pathogens (VZV and T. gondii) given their ability to persist latently
and reactivate, and produce a chronic inflammatory response, and
(2) pathogen burden operationalized in several novel ways utilizing
antibody levels, in an elderly cohort of MAs from the Sacramento
Area Latino Study on Aging (SALSA).
Methods
Ethics Statement
The University of Michigan Institutional Review Board
approved this study HUM00042648.
Study Population
SALSA is a longitudinal study of community-dwelling Latinos
residing in the Sacramento Valley of California. At baseline
(1998–1999), 1,789 Latino participants who were 60–101 years of
age were enrolled. Details of the recruitment and enumeration
process, as well as survey design, have been published previously
[18,19]. Over the course of the 10 year study period, total attrition
from deaths (n = 452), refusals (n = 169) and loss to follow up
(n = 147) in the cohort averaged 5.4% per year. Attrition due to
deaths averaged 3% per year, refusals 1.2% and loss to follow-up
1%. We excluded 168 participants who had a self-reported history
of stroke at baseline, and as a result, our analysis sub-sample
included 1,621 study subjects.
Study participants underwent a baseline in-home interview and
medical exam, where a trained bilingual interviewer collected a
fasting serum sample, data on socio-demographics, medical
history, medication usage, behavioral risk factors, and clinical,
cognitive and functional status. Seven in-home interviews were
conducted at 12–15 month intervals, to update the information
collected during the baseline interview. Fasting serum samples
were collected at baseline and during the 3–6th annual in-home
interviews. Study subjects also participated in semi-annual
telephone interviews (n = 6), where information on medical
history, medication usage, and demographics was collected. This
study was approved by the Institutional Review Boards at the
University of Michigan, and the University of California, San
Francisco and Davis, and all study subjects gave written consent.
Laboratory Analyses
Serum samples were tested at the Stanley Neurovirology
Laboratory of the Johns Hopkins University School of Medicine
for Immunoglobulin G (IgG) antibody levels to H. pylori, CMV,
HSV1, VZV, and T. gondii, measured by optical density ratio units,
using a commercially available solid-phase enzyme-linked immu-
nosorbent assay, with instructions from the manufacturers used to
determine sero-status. Individuals were categorized as sero-
negative to CMV, HSV1, H. pylori, and VZV if their absorbance
values were #0.9; equivocal if between 0.9 and 1.1; and sero-
positive if $1.1 [20]. The cut-point for sero-positivity to T. gondii
was 10 international units/ml [20]. For the analysis, individual
pathogen variables were defined using sero-status (positive/
negative, with equivocal values categorized as negative) and
antibody levels, based on IgG antibody levels. Pathogen burden
variables were defined as: (1) summed sero-positivity to 5
pathogens (for comparison with previous studies), (2) sum of the
number of pathogens with high antibody level, defined as IgG
antibody response in the top quartile of the baseline distribution
for the pathogen, and (3) average z-scored IgG antibody level
across all 5 pathogens, including those individuals sero-positive to
at least one pathogen.
Measures
Incident strokes were identified from study participants using
the following methods. At the baseline visit, participants were
asked ‘‘Has a doctor ever told you that you had a stroke?’’. At each
subsequent follow-up visit and semi-annual telephone conversa-
tion, participants were asked whether a doctor ever told them that
they had a stroke or cerebrovascular accident since the last
interview. Fatal strokes were identified from death certificates
using the international classification of disease-10 code 164. Death
certificates were obtained on 90.2% (n= 414) of those reported to
be deceased by their families and/or by vital statistics. Incident
strokes and stroke deaths confirmed by death certificate were
included as outcome events. Self-reported stroke has been shown
to accurately estimate incident stroke [21,22,23].
Variables included in the analysis as potential confounders
included hypertension, diabetes, hyperlipidemia, smoking, atrial
fibrillation, body mass index (BMI), coronary heart disease and/or
peripheral artery disease (PAD), education, age and gender. Two
blood pressure measurements were taken using an automatic
digital blood pressure monitor (OMRON MODEL: HEM-747
IC). Individuals were categorized as hypertensive (yes/no) if they
self-reported a physician diagnosis of hypertension, reported use of
anti-hypertensives, or had a sitting systolic blood pressure of at
least 140 mm Hg and/or a diastolic blood pressure of at least
90 mm Hg. Diagnosis of diabetic status (yes/no) was determined
by the presence of a serum fasting glucose of .125 mg/dl, self-
report of physician diagnosis of diabetes, or use of a diabetic
medication. Morning fasting serum samples were used to test for
total cholesterol using Reagent for Cholesterol (number 3313018;
Roche Diagnostics, Indianapolis, Indiana), low density lipoprotein
(LDL) cholesterol using the LDL Direct Liquid Select (number
7120; Equal Diagnostics) and high density lipoprotein (HDL)
cholesterol using the HDL Direct Reagent (number 3034569;
Roche Diagnostics, Indianapolis, Indiana). Hyperlipidemia (yes/
no) was defined as: having both LDL .100 mg/dl and
HDL,40 mg/dl or total cholesterol level .200 mg/dl. Smoking
status was categorized as ever/never for the analysis since only
11.10% of the study population were current smokers (n = 180).
History of atrial fibrillation (yes/no) was determined by self-
reported physician diagnosis within the previous 5 years. The body
mass index (BMI) variable was defined using height and weight
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measurements taken during in person interviews, and was
modeled continuously. Diagnosis of myocardial infarction, angina
pectoris, intermittent claudication, congestive heart failure, and
heart/coronary catheterization was determined by self-report of
any prior physician diagnosis of these conditions. A coronary heart
disease/PAD indicator variable was defined as having a history of
at least 1 of the following conditions: myocardial infarction, angina
pectoris, intermittent claudication, congestive heart failure, and
heart/coronary heart catheterization. Years of education was
categorized as 0–3, 4–11 and $12.
Baseline descriptive statistics for socio-demographics as well as
prevalence of stroke risk factors were calculated and compared by
incident stroke status using x2 tests for categorical variables and
Wilcoxon rank-sum test for continuous variables. Correlation
among the five persistent pathogens was assessed with x2 tests of
independence (sero-status) and spearman correlations (antibody
levels). Discrete-time logistic regression analyses were performed to
investigate associations between exposure to individual persistent
pathogens and measures of pathogen burden and incident stroke
using data from 13 time points. The discrete-time logistic
regression analysis performed here is asymptotically equivalent
to a Cox regression as the interval lengths shrink [24]. Even with
fairly wide intervals, this method produces very similar results, in
practice, to those from Cox models. This method was convenient
to apply to the SALSA study data, which had regular follow-up
intervals with one record per interval. It also allowed us to easily
incorporate time-varying covariates that were assumed constant
within an interval but varying from one interval to the next. We
used baseline covariate data and updated with longitudinally
collected covariate information when available. Since not all of the
variables of interest were ascertained at semi-annual visits, we used
the previous annual visit data to carry forward information on
hypertension, diabetes, hyperlipidemia, BMI, pathogen sero-status
and antibody level.
Statistical Analyses
The number of individuals with missing data for all 5 pathogens
at baseline, and at follow-up visits 3–6 was 523, 1,214, 1,193,
1,499 and 1,057, respectively. To justify carrying forward
pathogen data from follow-up visits with serum samples to
subsequent visits without samples, we assessed agreement between
sero-status at baseline and each subsequent follow-up visit, and
between each follow-up visit and succeeding visits (Kappa,
Gamma, Somers D, Lambda (symmetric and asymmetric), and
McNemar’s Test); the same comparisons were made for IgG
antibody level to each pathogen (intraclass correlation and
coefficient of variation). There was good agreement between
previous and subsequent sero-status and antibody level to each
pathogen (File S1).
For the discrete time logistic models, antibody levels for each
pathogen were modeled continuously. In order to interpret our
regression coefficients as the stroke risk for individuals in the 75th
versus the 25th percentile of antibody levels, we re-scaled the
continuous antibody level variables by dividing by their corre-
sponding interquartile range. Two levels of covariate adjustment
were used: (1) age, gender, education, and (2) age, gender,
education, diabetes, atrial fibrillation, smoking, BMI, coronary
heart disease/PAD, hypertension, and hyperlipidemia. Interac-
tions between the five pathogens were tested in our fully adjusted
models. Two-sided P values ,0.05, and confidence intervals that
did not overlap 1 were considered significant. All statistical
procedures were performed using SAS version 9.2 (SAS Institute,
Inc., Cary, North Carolina).
Results
Baseline characteristics of the study population by incident
stroke status (n = 1621) are shown in Table 1. During follow-up
164 incident strokes occurred. The mean (Standard deviation
(SD)) age of the study participants was 70.4 (7.04), with 41% male.
Study participants who experienced an incident stroke during
follow-up were more likely to report hypertension and diabetes at
baseline (P: 0.0008 and 0.02), respectively). Roughly 47% of the
population was born in the United States, with most of the
participants completing less than a high school education and
earning less than 2,000 dollars per month. Sero-positivity to each
individual pathogen was highest for H. pylori (66%), HSV1 (63%)
and CMV (60%), with the prevalence of both VZV and T. gondii
falling below 25%. There was no difference in the distribution of
sero-positivity to individual pathogens by incident stroke status.
Sero-positivity to each pathogen and antibody levels to H. pylori
were associated with baseline history of stroke (data not shown).
We found no correlations between antibody levels to any of the
persistent pathogens, except for between CMV and VZV (P:
0.0003).
Table 2 shows the baseline distribution of pathogen burden
defined as: summed sero-positivity to 1–5 pathogens and sum of
the number of pathogens eliciting a high antibody level, by
incident stroke status. The percentage of individuals who were
concurrently sero-positive to 1–5 pathogens was similar among
those who did and did not have an incident stroke during follow-
up (P: 0.49). In terms of the sum of the number of pathogens
eliciting a high antibody level by incident stroke status, we found
no difference with incident stroke status (P: 0.20), and 16.7% of the
study participants had zero pathogens eliciting a high antibody
level. The majority of the study population had high antibody
levels to only one pathogen (30.8%), followed by those individuals
with two (15.9%), three (7.2%) and four or five (1.2%) pathogens
concurrently eliciting a high antibody level.
The associations between IgG antibody levels to the 5
pathogens and stroke risk are shown in Table 3. There were no
associations between antibody levels to CMV, HSV1, T. gondii or
VZV and stroke risk before or after adjustment for covariates.
However, H. pylori antibody levels were associated with risk of
stroke (OR comparing IgG in the 75th versus 25th percentile: 1.58;
95% CI: 1.09, 2.28).
We performed a post-hoc sensitivity analysis of the association
between high antibody levels to H. pylori and incident stroke,
limiting the analysis to individuals who at baseline, were sero-
positive to H. pylori (n = 959), and found similar trends to those
reported in Table 3 (OR: 1.53; 95% CI: 1.03, 2.28). The
association between H. pylori and incident stroke was not
statistically significantly modified by antibody levels to CMV,
HSV-1, VZV, or T. gondii (data not shown). In terms of sero-
positivity to each individual persistent pathogen, no significant
associations with stroke risk were found (data not shown).
Table 4 shows associations between pathogen burden, defined
three different ways, and stroke risk. We observed positive
associations between incident stroke and both summed sero-
positivity to 0–5 pathogens as well as average antibody levels,
however, the associations were not significant before or after
multivariable adjustment. We found a positive association between
sum of the number of pathogens eliciting high antibody response
and stroke risk in unadjusted models (OR: 1.18, 95% CI: 1.04,
1.35), however, attenuation and loss of statistical significance
occurred after covariate adjustment.
Antibody Levels to Persistent Pathogens and Stroke
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Discussion
Using data from an elderly cohort of Latinos residing in
Sacramento County, California, we found a significant association
between IgG antibody levels to H. pylori and incident stroke after
adjusting for socio-demographics and stroke risk factors. In
contrast, we found no association between sero-positivity or IgG
antibody levels to CMV, HSV1, T. gondii, or VZV and risk of
stroke.
Our finding of null associations between sero-positivity to the
five persistent pathogens and incident stroke are in agreement with
existing prospective studies [13,14,15]. In contrast to these studies
based on sero-status, our findings pertaining to antibody levels to
H. pylori and stroke risk may be the result of our ability to more
accurately assess the effect of exposure to this pathogen, given the
evidence that antibody level may be a more consistent predictor of
inflammatory outcomes [17]. It is unclear why H. pylori alone was
associated with incident stroke. However, there are biologically
plausible pathways by which H. pylori may influence incident
stroke. For instance, lipopolysaccharides on the outer membrane
of H. pylori have been reported to bind to Toll-like receptors on
endothelial, monocyte and macrophage cells, which results in
endothelial damage and the initiation of atherosclerosis [25].
Recently, H. pylori was reported to increase diabetes risk in the
SALSA cohort [26]. However, when we adjusted for diabetes
status in our analysis, the ORs were not significantly attenuated,
suggesting that diabetes may not substantially mediate the H.
pylori-stroke association. Another possible pathway linking H. pylori
to incident stroke is through folic acid and Vitamin B12, both of
which are decreased with exposure to this pathogen, which results
in increased serum plasma homocysteine, a known risk factor for
cardiovascular disease and stroke [27,28,29,30,31,32].
An important link was recently made between sero-positivity to
H. pylori and incident dementia, which is most commonly caused
by Alzheimer’s disease [33]. Several mechanisms could explain
this reported association, including the accumulation of risk factors
Table 1. Baseline Participant Characteristics by Incident Stroke Status, SALSA, California, 1998–2008.
No Stroke (n=1457) Incident Stroke (n=164)
Characteristic N (%) N (%) P
Age (SD)* 70.2 (6.9) 72.6 (7.9) 0.0004
BMI* 29.74 (6.0) 29.85 (5.5) 0.5532
Men 602 (41.3) 71 (43.3) 0.6265
Nativity 0.8955
Mexico 677 (46.5) 71(43.3)
United States 686 (47.1) 82 (50.0)
Other 85 (5.8) 10 (6.1)
Education (years) 0.2878
0–3 464 (31.8) 59 (36.0)
4–11 552 (37.9) 59 (36.0)
$12 432 (.6) 45 (27.4)
Smoking Status 0.8795
Ever 769 (52.8) 92 (56.1)
Never 677 (46.5) 71 (43.3)
Income 0.7760
1,000/month 635 (43.6) 70 (42.7)
1,000–1999/month 441 (30.3) 54 (32.9)
$2,000/month 349 (24.0) 37 (22.6)
Hypertension 928 (63.7) 126 (76.8) 0.0008
Diabetes 433 (.7) 66 (40.2) 0.0215
Hyperlipidemia 846 (58.1) 92 (56.1) 0.07
Atrial Fibrillation 74 (5.1) 15 (9.2) 0.0901
Coronary Heart Disease/PAD 260 (17.8) 42 (25.6) 0.0532
Sero-positivity
CMV 882(60.5) 97 (59.2) 0.1889
H. pylori 959 (65.8) 105 (64.0) 0.4574
VZV 9 (20.5) 36 (22.0) 0.6192
HSV1 920(63.1) 94 (57.3) 0.3564
T. gondii 353 (24.2) 38 (23.2) 0.7506
All 5 pathogens 56 (3.8) 11 (6.7) 0.0807
*Mean(Standard Deviation (SD));BMI: Body mass index; N: number; P: p-value; SALSA: Sacramento Area Latino Study on Aging; CMV: Cytomegalovirus; H. pylori:
Helicobacter Pylori; VZV: Varicella zoster virus; HSV1: Herpes simplex virus type 1; T. gondii: Toxoplasma gondii.
doi:10.1371/journal.pone.0065959.t001
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for cardiovascular disease with chronic H. pylori exposure in the
elderly, which could increase both risk of developing dementia as
well as cognitive decline [33]. The previously discussed results, and
those of the current study, offer added support for the extra-gastric
effects of H. pylori, particularly among the elderly, and links two
vascular brain disorders to this particular persistent pathogen.
Future studies are needed to confirm the association between H.
pylori and stroke risk. If our association is confirmed, investigations
into possible mechanisms underlying this association are warrant-
ed.
In terms of our hypothesis that pathogen burden increases
stroke risk, our fully adjusted models did not support this
relationship. However, our null results are in agreement with the
majority of the existing studies [13,16]. On the other hand, Elkind
et al. reported a significant positive association between a
weighted index of pathogen burden (including H. pylori, C.
pneumoniae, CMV, HSV 1 and 2) and incident stroke (HR: 1.39,
95% CI: 1.02–1.90) [14]. The infectious disease burden index used
in our analysis was based on summed parameter estimates from
models containing individual sero-positive pathogen exposures,
which does not account for the potential variability in the strength
of the association between each persistent pathogen and stroke
risk. It is important to note, however, that comparisons across
studies with different study populations, exposure and outcome
definitions, as well as variables included in multivariable adjust-
ment, should be done with caution.
Given our result of a significant association between pathogen
burden defined as sum of the number of pathogens producing a
high antibody level and stroke risk that was attenuated from
unadjusted to fully-adjusted models, it is possible that one or more
of our adjustment variables lies on the causal pathway. For
example, inflammation may partially explain the association
between pathogen burden and incident stroke. Inflammatory
cytokines are associated with cerebral blood vessel constriction
[34,35,36], which links inflammation to hypertension, a predom-
inant modifiable risk factor for stroke [37,38,39,40,41]. Further-
Table 2. Baseline Pathogen Burden Defined as Summed Sero-positivity and Number of Pathogens With High IgG Antibody Level,
by Incident Stroke Status, SALSA, California, 1998–2008.
No Stroke (n =1457) Incident Stroke (n =164)
N (%) N (%) P
Summed Sero-positivity 0.4942
Missing 405 (27.8) 52 (31.7)
0 pathogens 17 (1.2) 2 (1.2)
1 pathogen 27 (1.9) 2 (1.2)
2 pathogens 144 (9.9) 16 (9.8)
3 pathogens 440 (30.2) 47 (28.7)
4 pathogens 368 (25.3) 34 (20.7)
5 pathogens 56 (3.8) 11 (6.7)
Number with High IgG Antibody Level
Missing 405 (27.8) 52 (31.7) 0.1957
0 pathogens 243 (16.7) 28 (17.1)
1 pathogen 458 (31.4) 41 (25)
2 pathogens 224 (15.4) 34 (20.7)
3 pathogens 108 (7.4) 8 (4.9)
4 or 5 pathogens 19 (1.3) 1 (0.6)
N: number; P: p-value; SALSA: Sacramento Area Latino Study on Aging.
doi:10.1371/journal.pone.0065959.t002
Table 3. IgG Antibody Levels to Persistent Pathogens (Comparing 75th and 25th Percentiles) and Incident Stroke, SALSA, California,
1998–2008.
CMV HSV1 T. gondii VZV H. pylori
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Model 1a 0.97 0.76, 1.23 0.93 0.73, 1.18 1.05 0.88, 1.26 1.04 0.86, 1.26 1.27 0.94, 1.72
Model 2b 0.85 0.65, 1.12 0.92 0.71, 1.19 1.10 0.91, 1.33 0.95 0.76, 1.19 1.38 1.00, 1.91
Model 3c 0.81 0.58, 1.12 0.77 0.56, 1.07 1.03 0.82, 1.29 0.93 0.71, 1.20 1.58 1.09, 2.28
CI: confidence interval; CMV: Cytomegalovirus; H. pylori: Helicobacter pylori; HSV1: Herpes simplex virus 1; OR: odds ratio; SALSA: Sacramento Area Latino Study on
Aging; T. gondii: Toxoplasma gondii; VZV: Varicella zoster virus;
aModel 1: unadjusted;
bModel 2: age, gender, education;
cModel 3: age, gender, education, diabetes, atrial fibrillation, smoking, coronary heart disease/PAD, hypertension, BMI, and hyperlipidemia.
doi:10.1371/journal.pone.0065959.t003
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more, pathogen burden, including sero-prevalence to C. pneu-
moniae, Mycoplasma pneumoniae, H. pylori and Coxsackie virus,
have been associated with hypertension [42]. Given these data, the
idea that exposure to more than one pathogen increases systemic
inflammation and hypertension risk, thereby increasing incident
stroke, is conceivable. The development of diabetes mellitus is also
associated with inflammatory markers [43,44,45]. The inflamma-
tory pathway that is induced by pathogen burden could increase
diabetes risk, especially given the recent report of an association
between H. pylori and incident diabetes in the SALSA cohort [26].
Our study has several strengths. To our knowledge, our study is
the first to use prospectively collected, population-based data to
investigate the link between IgG antibody levels to persistent
pathogens and stroke risk in MAs. We used discrete-time
regression, which may have permitted us to more accurately
assess the time-varying effect of persistent pathogen exposure on
stroke risk, and to account for temporal changes in risk factors. We
also operationalized pathogen burden in several different ways,
which has not been done in the stroke literature. Finally, our
research focused specifically on MAs, a group disproportionately
affected by persistent pathogens and stroke [3].
The following limitations of the current study should be
considered. First, our primary endpoint, incident stroke, was
largely based on self-report. However, sensitivity rates for self-
reported stroke ranging from 80–98% have been reported in the
elderly [46,47]. Any misclassification in the outcome would likely
bias our results toward the null, since self-reported stroke is
unlikely to be associated with exposure to persistent pathogens.
However, it is possible that individuals with infections caused by
H. pylori are more likely to seek medical attention, and as a result,
may be more likely to have mild strokes diagnosed. Nevertheless, it
is likely that most H. pylori infections are undiagnosed in this
population since a very small percentage of participants were
treated with a proton pump inhibitor and/or antibiotics compat-
ible with H. pylori infection over the study period [26]. It is possible
that those exposed to H. pylori may shun aspirin, thereby
increasing their risk of stroke, however, we were unable to account
for the use of immune altering or anti-inflammatory medications
in our multivariate models, due to a substantial number of
incomplete drug reports during follow-up. Given the likelihood
that medication usage changes with time, we could not justify
extrapolating these data. However, we found no difference in the
baseline distribution of aspirin use by H. pylori serostatus (x2 p-
value: 0.8565). Next, we could not distinguish between stroke
types, which may bias our associations towards the null, as
infection is more likely to be associated with ischemic stroke
through atherosclerotic mechanisms. Further, additional patho-
gens, such as C. pneumoniae and periodontal pathogens, which
have been previously studied for their links to stroke, were not
available [48,49,50,51,52]. Also, apolipoprotein E is involved in
cellular cholesterol and lipid packaging [53] and has been reported
to affect the outcome of many persistent pathogens
[54,55,56,57,58,59]. In the SALSA cohort, the prevalence of
Apolipoprotein E is13.4 percent. While APOE4 is not directly
related to our outcome of interest, it may be an important factor in
future studies aimed at understanding the effect of persistent
pathogens on chronic diseases. With our risk factor and pathogen
carry-forward methods, we assume that this information is
constant, which may not be true for all individuals, however,
our correlation analysis provided justification for this analytic
approach. Furthermore, in a post-hoc sensitivity analysis, we
found no significant associations between baseline pathogen
exposures and incident stroke during follow-up. However, we
would contend that our approach of using baseline pathogen data
and updating it with longitudinal data as available, allows us to
more accurately estimate the effect of antibody levels to persistent
pathogen on stroke risk, compared to using baseline antibody
levels only. Next, we assumed biologic interaction between the
persistent pathogens was absent when we defined pathogen
burden, which may not be true. It is possible that there are
additive, supra or sub-additive interactions between pathogens
[60]. Our study may have been under-powered to detect a
significant associations between individual persistent pathogens,
pathogen burden and incident stroke because of the relatively low
number of stroke cases over the study period. Lastly, the
generalizability of our study results is limited to elderly MAs.
Nevertheless, identification of novel risk factors in MAs is
particularly important given the growth of this aging population
in the US.
In summary, we found a significant association between
antibody levels to H. pylori and incident stroke among MAs. Null
associations were found for the other pathogens studied as well as
pathogen burden and incident stroke. Future studies are needed to
confirm our results.
Supporting Information
File S1 Supporting tables. Table S1. Correlations of
CMV serostatus by visit, SALSA, California, 1998–2008.
BL: baseline; FV3–6: follow-up visit 3–6; CMV: cytomegalovirus;
SALSA: Sacramento Area Latino Study on Aging; aAsymmetric;
bSymmetric. Table S2. Variability of CMV Immunoglob-
ulin G antibody levels by visit, SALSA, California, 1998–
2008. SALSA: Sacramento Area Latino Study on Aging; CMV:
cytomegalovirus. Table S3. Correlations of HSV1 serosta-
tus by visit, SALSA, California, 1998–2008. BL: baseline;
Table 4. Pathogen Burden Operationalized Three Different Ways and Incident Stroke, SALSA (n = 1621), California, 1998–2008.
Model 1a Model 2b Model 3c
Pathogen Burden OR 95% CI OR 95% CI OR 95% CI
Summed Sero-positivity (0–5) 1.10 0.91, 1.33 1.04 0.85, 1.27 1.00 0.80, 1.27
Number of Pathogens Eliciting High Antibody Response
(0–5)
1.18 1.04, 1.35 1.11 0.96, 1.30 1.04 0.87, 1.25
Average IgG Antibody Levels 1.19 0.90, 1.57 1.07 0.78, 1.46 0.86 0.58, 1.26
CI: Confidence Interval; OR: Odds Ratio; SALSA: Sacramento Area Latino Study on Aging;
aModel 1: unadjusted;
bModel 2: age, gender, education;
cModel 3: age, gender, education, diabetes, atrial fibrillation, smoking, coronary heart disease/PAD, BMI, hypertension, and hyperlipidemia.
doi:10.1371/journal.pone.0065959.t004
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FV3–6: follow-up visit 3–6; HSV1: Herpes Simplex Virus type 1;
aAsymmetric; bSymmetric; Gamma: range (21, 1); Kappa
interpretation: (0.0, Kappa .0.4 =marginal agreement, 0.4,
kappa .0.75= good agreement, Kappa .0.75: excellent agree-
ment; Somers D: range (21,1); Lambda (asymmetric and
symmetric): range (0,1). Table S4. Variability of HSV1
Immunoglobulin G antibody levels by visit, SALSA,
California, 1998–2008. HSV1: Herpes simplex virus type 1;
SALSA: Sacramento Area Latino Study on Aging. Table S5.
Correlations of H. Pylori serostatus by visit, SALSA,
California, 1998–2008. BL, baseline; FV3–6: follow-up visit 3–
6; H. pylori: Helicobacter Pylori; aAsymmetric; bSymmetric Gamma:
range (21, 1); Kappa interpretation: (0.0, Kappa .0.4 =mar-
ginal agreement, 0.4, kappa .0.75= good agreement, Kappa
.0.75: excellent agreement; Somers D: range (21,1); Lambda
(asymmetric and symmetric): range (0,1); SALSA: Sacramento
Area Latino Study on Aging. Table S6. Variability of H.
Pylori Immunoglobulin G antibody level by visit, SALSA,
California, 1998–2008. H. Pylori: Helicobacter pylori; SALSA:
Sacramento Area Latino Study on Aging. Table S7. Correla-
tions of VZV serostatus by visit, SALSA, California,
1998–2008. BL: baseline; FV3–6: follow-up visit 3–6;VZV,
Varicella Zoster Virus; aAsymmetric; bSymmetric; Gamma: range
(21, 1); Kappa interpretation: (0.0, Kappa .0.4 =marginal
agreement, 0.4, kappa .0.75= good agreement, Kappa .0.75:
excellent agreement; Somers D: range (21,1); Lambda (asymmet-
ric and symmetric): range (0,1); SALSA: Sacramento Area Latino
Study on Aging. Table S8. Variability of VZV Immuno-
globulin G antibody levels by SALSA, California, 1998–
2008. VZV: varicella zoster virus; SALSA: Sacramento Area
Latino Study on Aging. Table S9. T. gondii serostatus
correlations by visit, SALSA, California, 1998–2008. BL:
baseline; FV3–6: follow-up visit 3–6; T. gondii: Toxoplasma gondii;
aAsymmetric; bSymmetric; Gamma: range (21, 1); Kappa
interpretation: (0.0, Kappa .0.4 =marginal agreement, 0.4,
kappa .0.75= good agreement, Kappa .0.75: excellent agree-
ment; Somers D: range (21,1); Lambda (asymmetric and
symmetric): range (0,1); SALSA: Sacramento Area Latino Study
on Aging. Table S10. Variability of T. gondii Immuno-
globulin G antibody levels by visit SALSA, California,
1998–2008. T. gondii: Toxoplasma gondii; SALSA: Sacramento Area
Latino Study on Aging.
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